Cargando…

The Utility of Bronchoscopy in Hydralazine-Induced ANCA-Associated Vasculitis

Hydralazine is a vasodilator used for the management of hypertension, heart failure, and hypertensive emergencies in pregnancy. It has been implicated in the causation of drug-induced lupus erythematosus (DLE) and rarely with ANCA-associated vasculitis (AAV), which may present as a pulmonary-renal s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khosla, Atulya Aman, Saunders, Hollie, Helgeson, Scott, Hikida, Hiroshi, Aslam, Nabeel, Salem, Fadi, Albadri, Sam, Baig, Hassan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122576/ https://www.ncbi.nlm.nih.gov/pubmed/37095760 http://dx.doi.org/10.1155/2023/1461011

Ejemplares similares

Hydralazine-associated adverse events: a report of two cases of hydralazine-induced ANCA vasculitis
por: Zuckerman, Roman, et al.
Publicado: (2018)

Hydralazine-Induced Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis
por: Echevarria, Victoria, et al.
Publicado: (2023)

Hydralazine-Induced Vasculitis
por: Gandhi, Pulkit, et al.
Publicado: (2023)

Hydralazine-Induced Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: A Case Report and Literature Review
por: Alawneh, Diala, et al.
Publicado: (2022)

Hydralazine-Induced Vasculitis With Gastrointestinal Pseudomelanosis
por: Novikov, Aleksey, et al.
Publicado: (2014)

Hydralazine-Associated Vasculitis and Pulmonary Hemorrhage
por: Strubchevska, Kateryna, et al.
Publicado: (2023)

Hydralazine-Induced ANCA Associated Vasculitis (AAV) Presenting with Pulmonary-Renal Syndrome (PRS): A Case Report with Literature Review
por: Doughem, Karim, et al.
Publicado: (2021)

Hydralazine-induced vasculitis presenting with ocular manifestations
por: Hawn, Vivian S., et al.
Publicado: (2022)

ANCA-Associated Vasculitis: An Update
por: Almaani, Salem, et al.
Publicado: (2021)

Rare complication of a commonly used antihypertensive agent: A case of hydralazine‐induced ANCA‐associated vasculitis presenting as rapidly progressive glomerulonephritis
por: Warren, Kayle, et al.
Publicado: (2022)

Utility of interval kidney biopsy in ANCA-associated vasculitis
por: Chapman, Gavin B, et al.
Publicado: (2021)

Diffuse hydralazine-associated vasculitis with pathergy: An overlapping picture of Sweet syndrome and bullous vasculitis
por: Banbury, Sara, et al.
Publicado: (2023)

ANCA associated vasculitis
por: Hunter, Robert W, et al.
Publicado: (2020)

Utility of lung ultrasound in ANCA-associated vasculitis with lung involvement
por: Buda, Natalia, et al.
Publicado: (2019)

Hydralazine-associated antineutrophil cytoplasmic antibody vasculitis with pulmonary–renal syndrome
por: Aeddula, Narothama Reddy, et al.
Publicado: (2018)

Hydralazine-Induced Dual Antineutrophil Cytoplasmic Antibody Positive Vasculitis and Nephritis
por: Padala, Sandeep A, et al.
Publicado: (2020)

The immunopathology of ANCA-associated vasculitis
por: McKinney, Eoin F., et al.
Publicado: (2014)

Immunopathogenesis of ANCA-Associated Vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

ANCA-associated vasculitis of the appendix
por: Leaver, Phillip J, et al.
Publicado: (2019)

Comorbidities in ANCA-associated vasculitis
por: Kronbichler, Andreas, et al.
Publicado: (2020)

Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?
por: Wallace, Zachary S., et al.
Publicado: (2019)

13. CMV Reactivation in refractory ANCA-associated vasculitis
por: Hassan, Neelam, et al.
Publicado: (2019)

A hydralazine-induced triumvirate: Lupus, cutaneous vasculitis, and cryptococcoid Sweet syndrome
por: Skaljic, Meliha, et al.
Publicado: (2019)

Overlapping Syndromes: Drug-Induced Vasculitis From Hydralazine With Positive Antinuclear Antibodies
por: Kannan, Lakshmi, et al.
Publicado: (2023)

Focal Alveolar Hemorrhage Secondary to Hydralazine-Associated Antineutrophilic Cytoplasmic Antibody Vasculitis
por: Martinez Manzano, Jose M, et al.
Publicado: (2023)

Progress in treatment of ANCA-associated vasculitis
por: Smith, Rona M, et al.
Publicado: (2012)

Animal Models of ANCA Associated Vasculitis
por: Shochet, Lani, et al.
Publicado: (2020)

Eye involvement in ANCA positive vasculitis
por: Macarie, Sorin Simion, et al.
Publicado: (2020)

Mechanisms of thrombosis in ANCA-associated vasculitis
por: Misra, Durga Prasanna, et al.
Publicado: (2021)

Granulomatous Inflammation in ANCA-Associated Vasculitis
por: Müller, Antje, et al.
Publicado: (2021)

Complement Inhibition in ANCA-Associated Vasculitis
por: Tesar, Vladimir, et al.
Publicado: (2022)

The involvement of NETs in ANCA-associated vasculitis
por: Shiratori-Aso, Satoka, et al.
Publicado: (2023)

Hydralazine: Vasculitis, diffuse alveolar haemorrhage and pauci-immune crescentic glomerulonephritis : case report
Publicado: (2020)

Hydralazine-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Asymptomatic and Renal-Restricted Presentation
por: Tu, Wan, et al.
Publicado: (2021)

ANCA-associated Vasculitis in a Case of Congenital Leptin Deficiency
por: Yaseen, Atiya, et al.
Publicado: (2018)

The impact of COVID-19 pandemic on patients with ANCA associated vasculitis
por: Kant, Sam, et al.
Publicado: (2020)

Long-term outcomes in elderly patients with ANCA-associated vasculitis
por: McGovern, Dominic, et al.
Publicado: (2019)

Pathophysiology of ANCA-Associated Small Vessel Vasculitis
por: Kallenberg, Cees G. M.
Publicado: (2010)

Ocular disease in patients with ANCA-positive vasculitis
por: Watkins, Angela S., et al.
Publicado: (2009)

Levamisole-Induced ANCA Vasculitis and Cutaneous Necrosis
por: Tichauer, Matthew, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l8flsdkfn5cb0aouldefp8iqi1